COPD Flashcards
what are pharmacological recommendations for cold per GOLD 2025
bronchodilators (laba, lama)
ics
if symptoms persist, then escalate LABA/LAMA OR LABA-ICS COMBO
INTRODUCTION OF NEW THERAPIES SUCH AS :
ENSIFENTRINE
DUPILUMAB
WHAT ARE SURGICAL RECOMMENDATION FOR COPD PER GOLD 2025
LUNG VOLUME REDUCTION THERAPY
BRONCHOSCOPIC LUNG VOLUME REDUCTION (I.E ENDOBRONCHIAL COILS OR ENDOBRONCHIAL VALVES)
BULLECTOMY
LUNG TRANSPLANATAION
WHAT ARE THERAPY RECOMMENDATIONS FOR COPD PER GOLD 2025
SMOKING CESSATION
VACCINATIONS
PULM REHAB
PHARM TX
BRONCHODILATORS
ICS
ENSIFENTRINE
LUNG VOLUME REDUCTION SURGERY
BRONCHOSCOPIC LUNG VOL REDUCTION
O2 THERAPY
WHAT ARE THE NUTRITION RECOMMENDATIONS FOR COPD PER GOLD 2025
CHOOSE COMPLEX CARBS
ADEQUEATE AMOUNT OF PROTIENS
OPT FOR HEALTHY FATS
ENSURE VITAMINS AND MINERALS (D, C, AND E AND POTASSIUM AND CALCIUM)
LIMIT PORCESSED FOODS
INCREASE HYDRATIONS
WHAT TESTING RECOMMENDATIONS FOR COPD PER GOLD 2025
SPIROMETRY (PRE/POST BRONCHODILATOR)
LOW DOSE CT
CARDIOVASCULAR EVAL
PULM HYPERTENSION SCREENING
WHAT ARE THE DIFFERENT TYPES OF FREQUENCIES PER GOLD 2025 FOR COPD
EXACERBATION
SYMPTOM
MEDICATION USE
02 THERAPY
WHAT IS THE DIFFERENCE BETWEEN RESCUE OR RELIVER FOR COPD
USED INTERCHANGEABLY
THESE MEDICATIONS ARE TYPICALLY SHORT ACTING THAT WORK QUICKLY TO RELAX THE MUSCLES AROUND THE AIRWAYS
PRN MEDICATIONS PER GOLD 2025 FOR COPD
GROUP A - LOW SYMPTOMS/LOW EXACERBATION
GROUP B - HIGH SYMPTOMS/LOW EXACERBATION
GROUP E - HIGH EXACERBATION
WHAT IS THE DIFFERENCE BETWEEN MAINTENANCE MEDS AND RESCUE/RELIEVER
MAINTENANCE - SCHEDULED TIME USE//DAILY AND REGULAR BASIS
RESCUE/RELIEVER - AS NEEDED/PRN//FOR IMMEDIATE SYMPTOMS
WHAT ARE EXAMPLES OF MAINTENANCE THERAPY
LABA
LAMA
ICS
WHAT DO THE ABBREVIATIONS MEAN
QD
BID
TID
QID
Q6H
QD - EVERY DAY
BID - 2X A DAY
TID - 3X A DAY
QID - 4X A DAY
Q6H - EVERY 6 HOURS
HOW DOES A ABG LOOK LIKE FOR COPD PT
PH - ACIDOIC
PACO2 - ELEVATED
PA02 - LOWER
HC03- ELEVATED
HOW DOES A PFT LOOK LIKE FOR COPD PT
FVC -DECREASED
FEV1 - DECREASED
FEV1/FVC RATIO - DECREASED
PEF - DECREASED
PEF 50% - DECREASED
PEF200-1200 -DECREASED
TIDAL VOL -NORMAL OR INCREASED
IPV - NORMAL OR DECREASED
ERV - NORMAL OR DECREASED
RV - NORMAL OR INACREASED
VC -DECREASED
IC - NORMAL OR DECREASED
FRC - INCREASED
TLC - NORMAL OR INCREASED
RV/TLC RATIO NORMAL OR INCREASED
WHAT THERAPIES ARE USED TO ASSESS FOR IN ACUTE COPD EXACERBATION
SHORT ACTING BRONCHODILATORS (SABA FIRST LINE THERAPY)
SAMA - IPATROPIUM (ATROVENT)
COMBINATION THERAPY SABA + SAMA USED FOR BETTER SYMPTOM RELIEF AND INCREASED EFFECTIVENESS
SYSTEMIC STEROIDS (ORAL OR IV)
ABX - IF EXACERBATION IS LIKELY DUE TO A BACTERIAL INFECTION, PARTICULARLY IN PT WITH INCREASED SPUTUM PURULENCE OR WORSENG OF BASELINE SYMPTOMS
O2 THERAPY - GOAL SPO2 88-92%
EVALUATE FOR NIV
ASSESS FOR MECH VENT
HOW DOES A CHEST XRAY LOOK LIKE FOR A COPD PT
COMMON FINDINGS
TRANSLUCENT (DARK) LUNG FIELDS
DEPRESSED OR FLATTENED DIAPHRAGM
LONG AND NARROW HEART (PULLED DOWNWARD BY DIAPHRAGM)
INCREASED RETROSTERNAL OR SPACE (LATERAL RADIOGRAPH)
WHAT LABORATORY TESTS ARE DONE FOR
HCT/HGB - POLYCYTHERMIA
ELECTROLYTES (EARLY AND LATE STAGES) - HYPOCHLOREMIA
HYPERNATREMIA (NA+)
SPUTUM EXAM - SPRETOCOCUS PNEUMONAIE
HEAMOPHILLUS INFLUENZAE
MORAXELLA CATARRHALIS
BREATH SOUNDS FOR COPD PT
WHEEZE OFTEN SEEN EXPIRATION
DECREASED BREATH SOUNDS - DUE TO HYPERINFLATION AND AIR TRAPPING
CRACKLES OR RALES IN PT WITH CONSISTENT PULM INFECTIONS
WHAT IS A PINK PUFFER
A TERM USED TO DESCRIBE AN EMPHYSEMA OR COPD PT
PT HAVE BARREL CHEST DUE TO HYPERINFLATION
PUFFER REFERS TO THE FACT THESE PT ARE PURSED LIPPED
PT OFTEN REFERS TO THE FACT THE PT APPEARS WELL OXYGENATION (PINK SKIN TONE)
WHAT IS A BLUE BLOATER
A TERM USED TO DECSRIBE COPD PT WITH PREDOMINATELY CHRONIC BRONCHITIS
THESE PT TEND TO HAVE A CHRONIC COUGH, SPUTUM PORDUCTION AND CYANOSIS DUE TO SEVERE HYPOXEMIA
MAY DEVELOP RIGHT HEART FAILURE DUE TO LONG TERM PULM HYPERTENSION FROM HYPOXEMIA
HOW DOES THE BP LOOK FOR COPD PT
PULSE PRESSURE CAN BE WIDENED WHICH MAY INDICATE CARDIOVASCULAR STRAIN
ELEVATED SYSTOLIC BP
WHAT ARE THE 2 TYPES OF EMPHYSEMA
- PANACINAR - ABNORMAL WEAKENING AND ENLARGEMENT OF ALL ALVEOLI DISTAL TO THE TERMINOLE BROCHIOLES
- CENTRIACINAR - INVOLVE THE RESP BRONCHIOLES IN THE PROXIMAL (CENTRAL) PORTION OF THE ACINUS
MAJOR PATHOLOGIC OR STRUCTURAL CHANGES THAT ARE ASSOCIATED WITH CHRONIC BRONCHITIS
- CHRONIC INFLAMMATION AND THICKENING OF THE WALLS OF THE PERIPHERAL AIRWAYS
- EXCESSIVE MUCUS PRODUCTION AND ACCUMULATION
WHAT IS CHRONIC BRONCHITIS
THE PRESENCE OF A COUGH AND SPUTUM PRODUCTION FOR 3 MONTHS IN EACH CONSECUTEIVE YEARS, REMAIN A CLINICALLY AND EPIDEMICOLOGICALLY USEFUL BUT IT IS PRESENT IN A MINORITY OF SUBJECTS
WHAT IS EMPHYSEMA
CHARACTERIZED BY A WEAKENING AND PERSISTENT ENLARGEMENT OF THE AIR SPACES DISTAL TO THE TERMINAL BRONCHIOLES AND BY THE DESTRUCTION OF THE ALVEOLI WALLS